Comparative Pharmacology
Head-to-head clinical analysis: GRISEOFULVIN ULTRAMICROSIZE versus HEAD SHOULDERS CONDITIONER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GRISEOFULVIN ULTRAMICROSIZE versus HEAD SHOULDERS CONDITIONER.
GRISEOFULVIN, ULTRAMICROSIZE vs HEAD & SHOULDERS CONDITIONER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Binds to tubulin, disrupting microtubule function and inhibiting fungal cell mitosis; deposited in keratin precursor cells, making keratin resistant to fungal invasion.
Not applicable; this is a cosmetic conditioner. No pharmacological mechanism.
250-375 mg orally once daily or 500-750 mg orally once daily for severe infections.
Not applicable. Head & Shoulders Conditioner is a cosmetic product for external use on hair and scalp; no systemic dosing.
None Documented
None Documented
9-24 hours (mean 15 hours); prolonged in liver disease.
Not applicable for systemic elimination; local retention on hair/scalp lasts until next wash (typically 24-48 hours).
Renal (<1% unchanged); fecal (36% as metabolites); tissue deposition may persist for weeks.
Renal (urine): <1% unchanged; biliary/fecal: <1% as parent compound; majority remains on hair/scalp and is removed via washing and shedding. Systemic absorption negligible.
Category D/X
Category C
Antifungal
Antifungal/Antidandruff